http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5824511-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_16a85abf6a48de2e34e9b2ac4f7305c0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-88
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-88
filingDate 1995-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1998-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59dacbceb665934de52abf4aa533e8bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_002ddcde01dd6b49a6fc4677f0e70924
publicationDate 1998-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5824511-A
titleOfInvention Method for enhancing the production of hemoproteins
abstract A method for increasing the production of desired hemoproteins is described in which the rate-limiting step in a heme biosynthetic pathway is deregulated to increase the quantity of the rate-limiting enzyme. In yeast, transforming cells with the HEM2 gene increases the quantity of the rate-limiting enzyme ALA dehydratase. Free heme concentrations are reduced in cells by providing heme binding agents that complexes with overproduced heme, thereby reducing or eliminating heme feedback inhibition in the cell. The present invention permits investigation of other factors effecting the heme biosynthetic pathway by reducing interference from heme feedback inhibition within that pathway.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114945591-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11319544-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6100057-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114929736-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020219972-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012237986-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114874929-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SE-2051317-A1
priorityDate 1995-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5242892-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5635375-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4902620-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9013645-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4849348-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9216634-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5049493-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397217
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66868
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5481287
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129901017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406092
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53984864
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406091
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1148
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129140824
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6083
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID668
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127978224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398728

Total number of triples: 45.